ASHLEY STURGEON: Open Payments
NPI 1285955492 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,041 in 108 payments from 18 companies in 2025. Trend: 2023 $3,831 · 2024 $3,356 · 2025 $3,041
Food & beverage: $2,951Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $770 |
| UCB, Inc. | 19 | $564 |
| Regeneron Healthcare Solutions, Inc. | 16 | $423 |
| Janssen Biotech, Inc. | 14 | $270 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $228 |
| GENZYME CORPORATION | 8 | $206 |
| Amgen Inc. | 5 | $126 |
| REVANCE THERAPEUTICS, INC. | 1 | $125 |
| Paratek Pharmaceuticals, Inc. | 1 | $90 |
| Organon LLC | 4 | $53 |
Products named: DUPIXENT, Bimzelx, BOTOX, TREMFYA, ILUMYA, RINVOQ, OTEZLA, DAXXIFY.
Industry payments across TX — which companies pay providers there.
